Orthofix and SeaSpine combine in all-stock merger of equals; 0.4163 exchange ratio, ~$693M pro forma revenue

Orthofix Medical Inc.

SeaSpine shareholders to receive 0.4163 Orthofix shares per SPNE share; combined ownership 56.5% Orthofix, 43.5% SeaSpine.
Pro forma revenue ~$693M (trailing twelve months ended Sep 30, 2022); combined company has ~1,600 employees in 68 countries.
Jon Serbousek (Orthofix CEO) to be Executive Chairman; Keith Valentine (SeaSpine CEO) to be President and CEO.
Transaction expected to be adjusted EBITDA accretive by second year post-close; requires stockholder and antitrust approvals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.